Bcl9 Antibody

Product Specifications

Background

BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.

NCBI Gene ID

77578

Host

Rabbit

Reactivity

Human, Mouse, Rat

Immunogen

Recombinant protein of mouse Bcl9

Clonality

Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Cancer, Cell Cycle, Stem Cell, Transcription

Purification

Affinity purification

Positive Control

MCF7

Concentration

Batch dependent

Buffer

PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Store at -20˚ C. Avoid freeze / thaw cycles.

Calculated Molecular Weight

Observed: 160kDa/170kDa

Fragment

IgG

Symbol

BCL9

Positive Control 2

Mouse pancreas

NCBI Official Name

B cell CLL/lymphoma 9

NCBI Organism

Mus musculus

Other Product Names

2610202E01Rik, 8030475K17Rik, A330041G23Rik, Gm13B-cell CLL/lymphoma 9 protein, B-cell lymphoma 9 protein, bcl-9, nuclear co-factor of beta-catenin signalling